Q32 Bio Inc (QTTB)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $260.64M
Last updated: Nov 17, 2026 at 11:06 AM ET
Q32 Bio Inc (QTTB) Earnings: Report Dates and Results
Q32 Bio (QTTB) is expected to report earnings on May 3, 2027. In the quarter ended Sep 30, 2026, Q32 Bio reported EPS of -$0.26, above the -$0.36 estimate. It beat the EPS estimate in each of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
QTTB has an expected report date of May 3, 2027.
Earnings History
Of the 33 quarters below that had an estimate, QTTB beat 19 and missed 14. The widest gap in the table came in the quarter ended Dec 31, 2025, when EPS landed 632.56% above the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.26 | -$0.36 | -$0.42 - -$0.27 | +27.78% | Beat | N/A | 7 | 2 up, 1 down | Nov 4, 2026 | N/A |
| Jun 30, 2026 | -$0.44 | -$0.53 | -$0.61 - -$0.48 | +16.98% | Beat | N/A | 5 | 0 up, 0 down | Aug 5, 2026 | N/A |
| Mar 31, 2026 | -$0.54 | -$0.68 | -$0.84 - -$0.52 | +20.59% | Beat | N/A | 2 | 0 up, 0 down | May 5, 2026 | N/A |
| Dec 31, 2025 | $4.58 | -$0.86 | -$1.06 - -$0.63 | +632.56% | Beat | N/A | 3 | 1 up, 0 down | Mar 10, 2026 | $53.74M |
| Sep 30, 2025 | -$0.60 | -$1.19 | -$1.39 - -$0.99 | +49.58% | Beat | N/A | 2 | 0 up, 0 down | Nov 13, 2025 | N/A |
| Jun 30, 2025 | -$0.78 | -$0.98 | N/A | +20.41% | Beat | N/A | N/A | 0 up, 0 down | Aug 6, 2025 | N/A |
| Mar 31, 2025 | -$0.90 | -$1.23 | N/A | +26.83% | Beat | -187.4% | N/A | 0 up, 0 down | May 8, 2025 | N/A |
| Dec 31, 2024 | -$1.16 | -$1.53 | N/A | +24.18% | Beat | N/A | N/A | 0 up, 0 down | Mar 11, 2025 | N/A |
| Sep 30, 2024 | -$1.46 | -$1.45 | -$1.59 - -$1.00 | -0.69% | Miss | N/A | 5 | 0 up, 0 down | Nov 7, 2024 | N/A |
| Jun 30, 2024 | -$1.42 | -$1.04 | N/A | -36.54% | Miss | N/A | N/A | N/A | Aug 8, 2024 | N/A |
| Mar 31, 2024 | $1.03 | -$1.41 | N/A | +173.05% | Beat | N/A | N/A | N/A | May 9, 2024 | N/A |
| Dec 31, 2023 | -$0.28 | -$0.30 | N/A | +6.67% | Beat | N/A | N/A | N/A | Mar 13, 2024 | N/A |
| Sep 30, 2023 | -$0.57 | -$0.43 | N/A | -32.56% | Miss | N/A | N/A | N/A | Nov 14, 2023 | $1.86M |
| Jun 30, 2023 | -$0.61 | -$0.50 | N/A | -22.00% | Miss | N/A | N/A | N/A | Jul 27, 2023 | $3.21M |
| Mar 31, 2023 | -$0.50 | -$0.52 | N/A | +3.85% | Beat | -101.7% | N/A | N/A | May 11, 2023 | $2.95M |
| Dec 31, 2022 | -$10.80 | -$8.85 | N/A | -22.00% | Miss | N/A | N/A | N/A | Mar 29, 2023 | $802000 |
| Sep 30, 2022 | -$10.62 | -$8.21 | N/A | -29.38% | Miss | N/A | N/A | N/A | Dec 29, 2022 | $802000 |
| Jun 30, 2022 | -$9.18 | -$9.67 | N/A | +5.06% | Beat | N/A | N/A | N/A | Sep 28, 2022 | $802000 |
| Mar 31, 2022 | $28.62 | -$0.49 | N/A | N/A | N/A | N/A | N/A | N/A | Jun 28, 2022 | $802000 |
| Dec 31, 2021 | -$10.62 | -$10.33 | N/A | -2.80% | Miss | N/A | N/A | N/A | Mar 29, 2022 | $802000 |
| Sep 30, 2021 | -$9.72 | -$10.56 | N/A | +7.93% | Beat | N/A | N/A | N/A | Dec 29, 2021 | $1.68M |
| Jun 30, 2021 | -$9.72 | -$10.34 | N/A | +6.01% | Beat | N/A | N/A | N/A | Sep 28, 2021 | $2.19M |
| Mar 31, 2021 | -$0.36 | -$0.61 | N/A | +41.35% | Beat | N/A | N/A | N/A | Jun 28, 2021 | $29.30M |
| Dec 31, 2020 | -$11.16 | -$11.85 | N/A | +5.81% | Beat | N/A | N/A | N/A | Mar 30, 2021 | $980000 |
| Sep 30, 2020 | -$11.16 | -$0.81 | N/A | N/A | N/A | N/A | N/A | N/A | Nov 9, 2020 | $567000 |
| Jun 30, 2020 | -$14.04 | -$13.31 | N/A | -5.49% | Miss | N/A | N/A | N/A | Aug 10, 2020 | $567000 |
| Mar 31, 2020 | -$14.04 | -$12.41 | N/A | -13.13% | Miss | N/A | N/A | N/A | Jun 29, 2020 | $588000 |
| Dec 31, 2019 | -$9.90 | -$12.23 | N/A | +19.05% | Beat | N/A | N/A | N/A | Mar 30, 2020 | $563000 |
| Sep 30, 2019 | -$12.06 | -$10.79 | N/A | -11.76% | Miss | N/A | N/A | N/A | Nov 12, 2019 | $441000 |
| Jun 30, 2019 | -$10.98 | -$9.89 | N/A | -11.00% | Miss | N/A | N/A | N/A | Aug 8, 2019 | $392000 |
| Mar 31, 2019 | -$11.52 | -$9.71 | N/A | -18.61% | Miss | N/A | N/A | N/A | Jun 29, 2019 | $270000 |
| Dec 31, 2018 | -$9.18 | -$7.91 | N/A | -16.00% | Miss | N/A | N/A | N/A | Mar 30, 2019 | $1.20M |
| Sep 30, 2018 | -$7.20 | -$6.65 | N/A | -8.19% | Miss | N/A | N/A | N/A | Nov 13, 2018 | $1.60M |
| Jun 30, 2018 | -$0.16 | -$0.33 | N/A | +51.52% | Beat | N/A | N/A | N/A | Aug 13, 2018 | $1.40M |
| Mar 31, 2018 | -$0.15 | -$3.78 | N/A | +96.03% | Beat | N/A | N/A | N/A | Jun 29, 2018 | $1.13M |
| Dec 31, 2017 | -$0.32 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 30, 2018 | N/A |
Estimates made before a stock split are shown on the same share basis as the reported EPS.
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $2.30, a profit after a loss of $3.01 per share the year before. It was -$0.32 for the year ended Dec 31, 2017, the oldest of the 9 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $2.30 | N/A |
| Dec 31, 2024 | -$3.01 | N/A |
| Dec 31, 2023 | -$1.96 | N/A |
| Dec 31, 2022 | -$1.98 | N/A |
| Dec 31, 2021 | -$30.42 | N/A |
| Dec 31, 2020 | -$50.40 | N/A |
| Dec 31, 2019 | -$44.46 | N/A |
| Dec 31, 2018 | -$16.69 | N/A |
| Dec 31, 2017 | -$0.32 | N/A |
Frequently Asked Questions About QTTB
When is Q32 Bio's next earnings date?
Q32 Bio's next earnings report is expected for May 3, 2027.
Did QTTB beat earnings estimates last quarter?
Yes. Q32 Bio reported EPS of -$0.26 for the quarter ended Sep 30, 2026, above the -$0.36 estimate, a 27.78% surprise.
What EPS do analysts expect from QTTB next quarter?
The consensus EPS estimate for Q32 Bio for the quarter ending Dec 31, 2026 is -$0.31 from 10 analysts, with estimates from -$0.36 to -$0.24.
How often does QTTB beat earnings estimates?
Q32 Bio beat the EPS estimate in each of the last 8 quarters, with an average surprise of +102.36%.
QTTB pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors